Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA (RetroMTA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03631511 |
|
Recruitment Status :
Completed
First Posted : August 15, 2018
Last Update Posted : August 15, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Dental Pulp Exposure | Procedure: direct pulp capping with RetroMTA | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 3 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Histological Evaluation of Direct Pulp Capping on Human Pulp Tissue Using a RetroMTA |
| Actual Study Start Date : | April 3, 2016 |
| Actual Primary Completion Date : | March 20, 2017 |
| Actual Study Completion Date : | June 18, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: RetroMTA
Direct pulp capping with RetroMTA (BioMTA, Daejeon, Korea)
|
Procedure: direct pulp capping with RetroMTA
The study included seven caries-free third molars from three adults. These teeth were subjected to pulp exposure, direct capping with RetroMTA, and restoration with a composite resin. Seven months later, the teeth were clinically and radiographically evaluated. The teeth were then extracted and subjected to histological processing and evaluation. |
- Histological Evaluation of Direct Pulp Capping on Human Pulp Tissue Using a RetroMTA [ Time Frame: 7 months ]
Each histomorphologic section was scored from 1-3, with 1 representing the most desired result and 3 representing the least desired result.
Mineralized tissue bridge
- Complete
- Incomplete
- Absent
Mineralized tissue morphology
- Dentin associated with irregular hard tissue
- Only irregular hard tissue deposition
- No hard tissue deposition
Inflammatory response
- Absent
- Mild (inflammatory cells next to dentin bridge or area of pulp exposure only)
- Severe (all of the coronal pulp is infiltrated or necrotic)
Odontoblastic cell layer
- Presence of odontoblast cells and odontoblast-like cells
- Presence of odontoblast-like cells only
- Absent
Presence of bacteria
- Absence
- Presence of stained bacterial profiles along the coronal or apical walls
- Presence of stained bacterial profiles within the dental pulp
- Clinical Examination of Direct Pulp Capping on Human Pulp Tissue Using a RetroMTA [ Time Frame: 7 months ]
Number of participants with adverse events related to RetroMTA treatment
Periapical pathology
- absent
- present
The presence of pain
- absent
- present
Tooth sensitivity:
I. Reactions to thermal stimuli
- present
- absent
II. Electric sensitivity
- present
- absent
1 representing the most desired result and 2 representing the least desired result.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 30 Years to 37 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- The inclusion criteria were healthy patients with no contributing systemic conditions, who had at least one caries-free mature permanent third molar
Exclusion Criteria:
- The exclusion criteria included patients who had pulp inflammation, pulp necrosis, root resorption or periapical diseases
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03631511
| Poland | |
| Pomeranian Medical University in Szczecin | |
| Szczecin, Rybacka 1, Poland, 70-111 | |
| Study Director: | Alicja Nowicka, DDS, PhD | Department of Conservative Dentistry and Endodontics, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111, Szczecin, Poland | |
| Study Chair: | Till Dammaschke, DDS, PhD | Department of Periodontology and Operative Dentistry, Westphalian Wilhelms-University, Albert-Schweitzer-Campus 1, building W 30, 48149 Münster, Germany | |
| Study Chair: | Mariusz Lipski, DDS, PhD | Department of Preclinical Conservative Dentistry and Preclinical Endodontics, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111, Szczecin, Poland | |
| Study Chair: | Domenico Ricucci, MD, DDS | Private Practice, Piazza Calvario, 7, 87022 Cetraro (CS), Italy |
| Responsible Party: | Alicja Nowicka, DDS, PhD Alicja Nowicka, Pomeranian Medical University Szczecin |
| ClinicalTrials.gov Identifier: | NCT03631511 |
| Other Study ID Numbers: |
Direct capping RetroMTA |
| First Posted: | August 15, 2018 Key Record Dates |
| Last Update Posted: | August 15, 2018 |
| Last Verified: | August 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
direct pulp capping, RetroMTA, histological evaluation |
|
Dental Pulp Exposure Dental Pulp Diseases Tooth Diseases Stomatognathic Diseases |

